Single Nucleotide Polymorphism Genotyping Market

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Single Nucleotide Polymorphism Genotyping Market contains market size and forecasts of Single Nucleotide Polymorphism (SNP) Genotyping in Global, including the following market information:

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Single Nucleotide Polymorphism (SNP) Genotyping market was valued at 17390 million in 2021 and is projected to reach US$ 63010 million by 2028, at a CAGR of 20.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Transversion Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Single Nucleotide Polymorphism (SNP) Genotyping include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, Roche, Qiagen, Luminex Corporation and Enzo Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Single Nucleotide Polymorphism (SNP) Genotyping companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Single Nucleotide Polymorphism (SNP) Genotyping Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, by Type, 2021 (%)

Transversion

Transition

Global Single Nucleotide Polymorphism (SNP) Genotyping Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, by Application, 2021 (%)

Diagnostics

Animal

Plant

Research

Others

Global Single Nucleotide Polymorphism (SNP) Genotyping Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Single Nucleotide Polymorphism (SNP) Genotyping revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Single Nucleotide Polymorphism (SNP) Genotyping revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Illumina

Affymetrix

Applied Biosystems

Agilent Technologies

Beckman Coulter

Roche

Qiagen

Luminex Corporation

Enzo Life Sciences

Bio-rad

Sequenom

Ocimum Biosolutions

GE Healthcare

GenScript

Douglas Scientific

BGI

Beijing Sunbiotech

HuaGene Biotech

Generay Biotech

Benegene

Shanghai Biochip

GENESKY

HD Biosciences